41ACTIVITIES
1ORGS REPRESENTED
46BILLS
Organizations represented
1Orgs whose LD-2 filings list Judith as an active lobbyist, sorted by activity volume.
Bills they file on
46S. 229623 mentions
S. 65214 mentions
S. 83214 mentions
S. 89114 mentions
S. 93214 mentions
H.R. 94614 mentions
H.R. 126214 mentions
H.R. 149214 mentions
H.R. 221414 mentions
H.R. 394413 mentions
H.R. 412113 mentions
H.R. 421313 mentions
S. 225613 mentions
S. 35513 mentions
S. 141413 mentions
+ 31 more bills referenced in their activities
Topics in Filings
71Policy topics Judith files on across all their LD-2 activities.
One Big Beautiful Bill Act×39
Inflation Reduction Act×28
Drug cost and pricing policy×28
Rural Development×26
Modernizing and Ensuring PBM Accountability×14
Accountability, and Integrity Now and for the Future×14
Vaccine policy×14
Pharmacy Benefit Manager reform×14
Drug importation policy×14
FDA policy×14
Orphan Drug Act×14
Compounding policy×14
Show all 71 topics (+59 more) ▾
Supply chain policy×14
Clinical trial policy×14
Issues 340B drug discount program policy×14
Biosimilar approval and reimbursement policy×14
Artificial intelligence policy×14
Part D redesign and policy×14
Part B policy×14
Medicare rebate policy×14
Center for Medicare and Medicaid Innovation×14
Medicaid rebate policy×14
FDA Modernization×14
Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H×13
Res. 566: Providing for consideration of the Senate amendment to the bill×13
Biosimilar Red Tape Elimination Act×13
Bipartisan Health Care Act×12
BIOSECURE Act×12
IRA price negotiation expansion policy×12
Most Favored Nation×12
MAHA Commission Report×12
Make Our Children Healthy Again Competition policy×12
Issues 340B rebate pilot program Patient assistance program policy×12
Biosimilars Access and Affordability Act×12
Legislative Branch×11
PBM Price Transparency and Accountability Act×11
Mikaela Naylon Give Kids a Chance Act×11
PBM Reform×11
HELP Copays Act×11
Antimicrobial resistance policy×11
GENErating cost Reductions for U.S×11
Medicare Against Rising Drugs Costs×11
Energy and Water Development×10
Military Construction and Veterans Affairs, and Extensions Act, 2026×10
Government funding policy×10
CLEAR LABELS Act×10
Most Favored Patients Act×10
FAIR ACT×10
SECURE Rx Act×10
User fee issues×4
Give Kids a Chance Act×3
Antimicrobial resistance×3
Science, and Related Agencies Appropriations Act, 2026×3
Accelerated approval policy×2
Competition policy×2
Patient assistance program policy×2
Drug shortages policy×2
Insulin policy×2
Medicaid waiver policy×2
Protecting Patients from Deceptive Drug Ads Act×1
Innovation in Pediatric Drugs Act×1
Pandemic preparedness policy×1
Saving Seniors Money on Prescriptions Act×1
Military Construction×1
Expedited Acccess to Biosimilars Act×1
MAPS Act×1
Medication Affordability and Patent Integrity Act×1
Orphan Cures Act×1
Prescription Information Modernization×1
MVP Act×1
Open Payments Expansion Act×1
Issue mix
LDA general-issue codes weighted by activity count.
Health Issues14
Medicare/Medicaid14
Budget/Appropriations13